These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
177 related items for PubMed ID: 7979307
21. Comparative activities of eight quinolones against members of the Bacteroides fragilis group. Borobio MV, Conejo M, Ramirez E, Suarez AI, Perea EJ. Antimicrob Agents Chemother; 1994 Jun; 38(6):1442-5. PubMed ID: 8092852 [Abstract] [Full Text] [Related]
24. Comparison of the in vitro activities of Bay 12-8039, a new quinolone, and other antimicrobials against clinically important anaerobes. Aldridge KE, Ashcraft DS. Antimicrob Agents Chemother; 1997 Mar; 41(3):709-11. PubMed ID: 9056020 [Abstract] [Full Text] [Related]
31. Patterns of susceptibility to fluoroquinolones among anaerobic bacterial isolates in the United States. Goldstein EJ. Clin Infect Dis; 1993 Jun; 16 Suppl 4():S377-81. PubMed ID: 8324151 [Abstract] [Full Text] [Related]
32. In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacin. Barry AL, Fuchs PC. Antimicrob Agents Chemother; 1991 May; 35(5):955-60. PubMed ID: 1906696 [Abstract] [Full Text] [Related]
33. Comparative in vitro activities of a new quinolone, WIN 57273, and piperacillin plus tazobactam against anaerobic bacteria. Venezia RA, Yocum DM, Robbiano EM, Echols RM. Antimicrob Agents Chemother; 1990 Sep; 34(9):1858-61. PubMed ID: 2178340 [Abstract] [Full Text] [Related]
34. In vitro and in vivo evaluations of A-80556, a new fluoroquinolone. Clement JJ, Tanaka SK, Alder J, Vojtko C, Beyer J, Hensey D, Ramer N, McDaniel D, Chu DT. Antimicrob Agents Chemother; 1994 May; 38(5):1071-8. PubMed ID: 8067740 [Abstract] [Full Text] [Related]
35. The in-vitro activity of tosufloxacin, a new fluorinated quinolone, compared with that of ciprofloxacin and temafloxacin. King A, Bethune L, Phillips I. J Antimicrob Chemother; 1991 Nov; 28(5):719-25. PubMed ID: 1663930 [Abstract] [Full Text] [Related]
37. In vitro activity of BAY 12-8039, a new 8-methoxyquinolone. Dalhoff A, Petersen U, Endermann R. Chemotherapy; 1996 Nov; 42(6):410-25. PubMed ID: 8957575 [Abstract] [Full Text] [Related]
38. Comparison of activities of trovafloxacin (CP-99,219) and five other agents against 585 anaerobes with use of three media. Hecht DW, Osmolski JR. Clin Infect Dis; 1996 Dec; 23 Suppl 1():S44-50. PubMed ID: 8953106 [Abstract] [Full Text] [Related]
39. Comparative in vitro activities of azithromycin, Bay y 3118, levofloxacin, sparfloxacin, and 11 other oral antimicrobial agents against 194 aerobic and anaerobic bite wound isolates. Goldstein EJ, Nesbit CA, Citron DM. Antimicrob Agents Chemother; 1995 May; 39(5):1097-100. PubMed ID: 7625795 [Abstract] [Full Text] [Related]